Search

everythinglearnresearchcommunity

for

Search:↓

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

The market for these drugs is expected to grow.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5α-Reductase inhibitors can negatively impact sexual function.

The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Dutasteride reduces DHT more effectively than finasteride.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Finasteride reduces bleeding risk during prostate surgery.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Finasteride and dutasteride may cause macular abnormalities.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Finasteride and dutasteride can affect sexual function in BPH patients.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Low-intensity shock wave therapy is effective in treating erectile dysfunction in diabetic patients.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.